This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Facts about Astrocytic phosphoprotein PEA-15.
Inhibits both TNFRSF6- and TNFRSF1A-mediated CASP8 action and apoptosis. Regulates glucose transport by controlling both the content of SLC2A1 glucose transporters on the plasma membrane and the insulin-dependent trafficking of SLC2A4 from the cell interior to the surface.
Human | |
---|---|
Gene Name: | PEA15 |
Uniprot: | Q15121 |
Entrez: | 8682 |
Belongs to: |
---|
No superfamily |
HMAT1; HMAT115kD; HUMMAT1H; MAT1H; PEA15; PEA-15; PED; PED15 kDa phosphoprotein enriched in astrocytes; phosphoprotein enriched in astrocytes 15; Phosphoprotein enriched in diabetes
Mass (kDA):
15.04 kDA
Human | |
---|---|
Location: | 1q23.2 |
Sequence: | 1; NC_000001.11 (160205384..160215376) |
Ubiquitously expressed. Most abundant in tissues such as heart, brain, muscle and adipose tissue which utilize glucose as an energy source. Lower expression in glucose- producing tissues. Higher levels of expression are found in tissues from individuals with type 2 diabetes than in controls.
Cytoplasm. Associated with microtubules.
PMID: 8662970 by Estelles A., et al. The major astrocytic phosphoprotein PEA-15 is encoded by two mRNAs conserved on their full length in mouse and human.
PMID: 9670003 by Condorelli G., et al. PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus.